Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2007
08/23/2007WO2006116369A3 Method for treating dementia or alzheimer's disease with a cd20 antibody
08/23/2007WO2006044115A3 Method of treating parkinson's disease by convection-enhanced infusion of glial cell-line derived neurotrophic factor (gdnf) to the putamen
08/23/2007WO2002097035A3 Secreted proteins
08/23/2007US20070197829 Process for the synthesis and crystalline form agomelatine
08/23/2007US20070197793 Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
08/23/2007US20070197659 Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
08/23/2007US20070197654 Combination of a cb1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease
08/23/2007US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
08/23/2007US20070197602 Combined pharmaceutical composition
08/23/2007US20070197601 Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy
08/23/2007US20070197595 Benzisoxazoles
08/23/2007US20070197572 Oxycodone polymorphs
08/23/2007US20070197570 Indanol derivative
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone
08/23/2007US20070197514 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity
08/23/2007US20070197511 Neuroprotective bicyclic compouds and methods for their use
08/23/2007US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient
08/23/2007US20070197499 Pharmaceutical compounds
08/23/2007US20070197482 Regulation of guanine nucleotide exchange factor for a protein belonging to the rap family of small gtpases
08/23/2007US20070196857 Determination of risk and treatment of complications of prematurity
08/23/2007US20070196481 Sustained-release tablet composition
08/23/2007US20070196417 Therapeutic polyanhydride compounds for drug delivery
08/23/2007US20070196370 Type 2 cytokine receptor and nucleic acids encoding same
08/23/2007DE102007008231A1 Pharmazeutische Zubereitung zur Behandlung der Migräne A pharmaceutical preparation for the treatment of migraine
08/23/2007DE102005062417A1 Kompositionen mit spezifischen und unspezifischen Lipidantagonisten Compositions with specific and nonspecific lipid antagonists
08/23/2007CA2645734A1 Method of treating inflammatory diseases
08/23/2007CA2642828A1 Affinity regions
08/23/2007CA2642561A1 Novel pharmaceutical compositions for optimizing substitution treatments and extending the pharmacopoeia to global treatment of addictions
08/23/2007CA2642338A1 Adhesive preparation comprising sufentanil and methods of using the same
08/23/2007CA2642212A1 Novel tricyclic dihydropyrazines as potassium channel openers
08/23/2007CA2642081A1 Use of 5h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders
08/23/2007CA2641917A1 Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
08/23/2007CA2641913A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
08/23/2007CA2641767A1 Novel diazabicycloalkane derivatives and their medical use
08/23/2007CA2641384A1 Ibandronate regimen for treating metastatic bone pain
08/23/2007CA2641254A1 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
08/23/2007CA2640807A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators
08/23/2007CA2633588A1 Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
08/22/2007EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof
08/22/2007EP1820854A2 JNK3 modulators and methods of use
08/22/2007EP1820806A1 Affinity regions
08/22/2007EP1820505A1 Analgesic
08/22/2007EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
08/22/2007EP1820501A1 Therapeutic agent for depletion of an unwanted protein population from plasma
08/22/2007EP1819713A1 Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity
08/22/2007EP1819709A1 Novel diazabicyclic aryl derivatives as cholinergy ligands
08/22/2007EP1819676A2 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
08/22/2007EP1819342A1 Quinoline tachykinin receptor antagonists
08/22/2007EP1819328A1 Adjunctive therapy for depression
08/22/2007EP1648904B1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
08/22/2007EP1615919B1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands
08/22/2007EP1610785B1 Pharmaceutical combination for the treatment of spasticity and/or pain
08/22/2007EP1592431A4 Method of modulating il-6
08/22/2007EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/22/2007EP1567502B1 Substituted dihydrophenanthridinesul fonamides
08/22/2007EP1560809B1 Cyclohexylurea derivatives
08/22/2007EP1537122B1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
08/22/2007EP1534807B1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
08/22/2007EP1527073B1 Benzothiophene urea, benzofurane urea, and indole urea, and use of the same as alpha-7 achr agonists
08/22/2007EP1499320B1 Novel compounds
08/22/2007EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
08/22/2007EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/22/2007EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
08/22/2007EP1379513B1 Prodrugs of cox-2 inhibitors
08/22/2007EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS
08/22/2007EP1183256B1 Purine derivatives, preparation method and pharmaceutical compositions containing same
08/22/2007EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/22/2007EP1052975B1 Propofol composition containing sulfite
08/22/2007CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands
08/22/2007CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/22/2007CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
08/22/2007CN1332946C Premedicine acting on nervous centralis system
08/22/2007CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
08/22/2007CN1332690C Technique for preparing Yueju capsule and quality control method
08/22/2007CN1332667C Compound preparation for resisting Parkinson's disease
08/22/2007CN1332666C Compound preparation for resisting senile dementia
08/22/2007CN1332665C Nicotine-containing film preparation
08/22/2007CN1332656C Application of compound laetispicine in the process for preparing pharmaceutical composition
08/22/2007CN101023081A Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/22/2007CN101023075A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
08/22/2007CN101023066A Substituted triazines as prion protein ligands and their use to detect or remove prions
08/22/2007CN101023056A Levodopa prodrugs, and compositions and uses thereof
08/22/2007CN101022829A Treatment of polychondritis or mononeuritis multiplex by using an antibody against CD20
08/22/2007CN101022817A Therapeutic or preventive agent for diabetic neuropathy
08/22/2007CN101022806A Use of (4-alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease
08/22/2007CN101022801A Use of N-aryl diazaspiracyclic compounds in the treatment of addiction
08/22/2007CN101022795A Novel formulation for L-tryptophane comprising carbidopa/benserazide
08/22/2007CN101022794A Method for treating nervous system disorders and conditions
08/22/2007CN101022784A Infusion and injection solution of levodopa
08/22/2007CN101020715A Process of extracting and preparing deer nerve growth factor (DEER NGF)
08/22/2007CN101020706A Helicid medicine containing 1,5-benzothioazatro cycle with tranquilizing activity and its prepn process
08/22/2007CN101020705A Helicid-Mannich alkali medicine with transquilizing activity and its prepn process
08/22/2007CN101020704A Helicid derivative as medicine with tranquilizing activity and its prepn process
08/22/2007CN101020698A Benzothiazole aniline compound marked with Tc-99m and its prepn process and application
08/22/2007CN101020661A (-)-meptazinol carbamate derivative and/or its salt and their prepn and use
08/22/2007CN101020660A Process of extracting huperzine B from plant medicine material huperzine serrate
08/22/2007CN101020659A 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application
08/22/2007CN101020049A Use of ulinastatin in preparing medicine for treating and/or preventing spinal cord injury
1 ... 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 ... 1833